In a patient two weeks post‑stem‑cell transplant with BK‑virus‑associated hemorrhagic cystitis, mild renal impairment, and stable blood counts, should I give an 80 mg IV furosemide (Lasix) dose followed by a 40 mg IV dose at midday to achieve diuresis and prevent fluid overload?

Furosemide Dosing for Diuresis in Post-Stem-Cell Transplant BK Hemorrhagic Cystitis

Your proposed regimen of 80 mg IV furosemide followed by 40 mg IV at midday is appropriate and aligns with standard supportive care for BK-virus-associated hemorrhagic cystitis, provided the patient's systolic blood pressure is ≥90–100 mmHg, serum sodium is >125 mmol/L, and renal function permits (creatinine ≤2 mg/dL or eGFR ≥30 mL/min/1.73 m²). 1, 2

Clinical Context and Rationale

• Forced diuresis with aggressive hydration is the cornerstone of supportive care for BK-virus hemorrhagic cystitis after stem-cell transplantation, as it dilutes urine, reduces bladder contact time with viral particles, and minimizes clot formation. 3, 4, 5
• The patient is two weeks post-transplant, which falls within the typical 17–49 day window for BK-HC onset; maintaining high urine output (target >0.5 mL/kg/h) is critical during this period. 6, 7, 8
• No antiviral therapy has proven efficacy for BK-HC; cidofovir is used sporadically but is not standard, and supportive care (hydration, diuresis, transfusion support) remains the mainstay. 3, 4, 9, 7

Pre-Administration Safety Checklist

Before giving either furosemide dose, verify:

• Systolic blood pressure ≥90–100 mmHg: furosemide can precipitate hypotension and worsen tissue perfusion in hypotensive patients. 1, 2
• Serum sodium >125 mmol/L: severe hyponatremia (<120–125 mmol/L) is an absolute contraindication. 1, 2
• Serum potassium 3.5–5.0 mmol/L: severe hypokalemia (<3 mmol/L) requires correction before diuretic administration. 1, 2
• Creatinine ≤2 mg/dL or eGFR ≥30 mL/min/1.73 m²: mild renal impairment is not a contraindication, but anuria is. 1, 2
• Detectable urine output: anuria mandates immediate cessation of diuretics. 1, 2

Dosing Protocol

Initial Dose (80 mg IV)

• Administer 80 mg IV furosemide as a slow push over 1–2 minutes in the morning. 1, 2
• This dose is appropriate for a patient with mild renal impairment and stable blood counts who requires aggressive diuresis; it is within the recommended range for patients with prior diuretic exposure or significant volume overload. 1, 2

Midday Dose (40 mg IV)

• Give 40 mg IV furosemide at midday (approximately 6 hours after the first dose) to maintain continuous diuretic effect, as furosemide's duration of action is only 6–8 hours. 1
• Split dosing (80 mg + 40 mg = 120 mg total daily) is more effective than a single morning dose because it avoids the 16–18 hour period without active diuresis that occurs with once-daily administration. 1

Maximum Daily Limits

• Do not exceed 100 mg in the first 6 hours or 240 mg in the first 24 hours without close monitoring. 1, 2
• Your proposed total of 120 mg/day is well within these limits and appropriate for this clinical scenario. 1, 2

Monitoring Requirements

Hourly (First 24 Hours)

• Urine output: place a bladder catheter and target >0.5 mL/kg/h to assess diuretic response. 1, 2
• Blood pressure: check every 15–30 minutes in the first 2 hours after each dose to detect hypotension. 1

Daily

• Morning weight (same time, before breakfast): aim for 0.5–1.0 kg loss per day until euvolemia is achieved. 1, 2
• Clinical exam: assess for resolution of peripheral edema, jugular venous distension, and pulmonary crackles. 1, 2

Every 3–7 Days (or Sooner if Clinically Indicated)

• Serum electrolytes (Na, K, Cl, HCO₃): hypokalemia occurs in ~3.6% of furosemide recipients and requires aggressive repletion. 1
• Renal function (creatinine, BUN, eGFR): a transient rise in creatinine ≤0.3 mg/dL is acceptable if the patient remains asymptomatic and volume status improves. 1, 2
• Magnesium: furosemide depletes magnesium stores, and deficiency impairs potassium repletion; correct magnesium before aggressive potassium supplementation. 1

Absolute Contraindications Requiring Immediate Cessation

Stop furosemide immediately if:

• Systolic blood pressure drops <90 mmHg without circulatory support. 1, 2
• Serum sodium falls <120–125 mmol/L. 1, 2
• Serum potassium drops <3.0 mmol/L. 1, 2
• Anuria develops (no urine output). 1, 2
• Progressive renal failure with rising creatinine despite adequate diuresis. 1, 2

Management of Inadequate Response

If urine output remains <0.5 mL/kg/h after 2 hours:

• Double the dose (e.g., 80 mg → 160 mg for the next dose), but do not exceed 160–200 mg per individual bolus. 1, 2
• Consider continuous infusion (5–10 mg/hour after a 40 mg loading dose, maximum rate 4 mg/min) if resistance persists. 1, 2
• Add a second diuretic class (hydrochlorothiazide 25 mg PO, spironolactone 25–50 mg PO, or metolazone 2.5–5 mg PO) rather than escalating furosemide beyond 160 mg/day. 1, 2

BK-Virus-Specific Considerations

• BK viruria is detected in 71–86% of stem-cell transplant recipients, and high-level viruria (>10⁷ copies/mL) is a prognostic indicator for hemorrhagic cystitis. 6, 7, 8
• Preemptive treatment with forced diuresis prevents HC in 67% of patients with high BK viral loads. 8
• Cytomegalovirus viruria coinfection occurs in 17% of BK-HC cases but is typically not treated; antibacterial therapy is reserved for concomitant urinary tract infections (28%) or infections at other sites (57%). 7
• Symptoms typically last a median of 27 days (longer for grade 3–4 HC), and BK-HC does not significantly impact overall survival, graft-versus-host disease-free relapse-free survival, or long-term renal function. 7

Common Pitfalls to Avoid

• Do not withhold furosemide out of fear of mild azotemia (creatinine rise <0.3 mg/dL); transient renal function worsening is acceptable when the patient remains asymptomatic and volume status improves. 1, 2
• Do not under-dose furosemide (e.g., 20–40 mg total daily) in a patient requiring aggressive diuresis for BK-HC; this delays euvolemia and prolongs symptoms. 1, 2
• Do not exceed 160 mg/day furosemide without adding a second diuretic class, as higher doses provide no additional benefit and increase adverse-event risk. 1, 2
• Do not administer furosemide to hypotensive patients expecting hemodynamic improvement; it worsens tissue perfusion and can precipitate cardiogenic shock. 1, 2

Electrolyte Management

Hypokalemia (K <3.5 mmol/L)

• Add spironolactone 25–50 mg PO daily as a potassium-sparing aldosterone antagonist. 1, 2
• If spironolactone is not used, supplement oral potassium chloride 20–40 mEq/day. 1, 2

Hypomagnesemia

• Correct magnesium deficiency before aggressive potassium repletion; magnesium oxide 400 mg PO twice daily is suggested. 1

Hyponatremia

• If serum sodium drops to 121–125 mmol/L, reduce or temporarily stop diuretics and implement strict fluid restriction. 1, 2

Concurrent Therapies

• Mesna prophylaxis is typically given with post-transplant cyclophosphamide to prevent hemorrhagic cystitis, but it does not prevent BK-virus-associated HC. 7
• Cidofovir (1.5 mg/kg 3 times weekly or 5 mg/kg weekly) has been used in refractory cases, but randomized trials are lacking, and supportive care alone achieves complete clinical response in most patients. 3, 6, 4, 9, 7
• Antibacterial therapy should be reserved for documented urinary tract infections or concomitant infections at other sites, not for prophylaxis. 7

Summary Algorithm

Step	Action	Details
1	Verify safety checklist	SBP ≥90–100 mmHg, Na >125 mmol/L, K 3.5–5.0 mmol/L, Cr ≤2 mg/dL, urine output present [1,2]
2	Administer morning dose	80 mg IV furosemide over 1–2 minutes [1,2]
3	Monitor early response	Urine output hourly (target >0.5 mL/kg/h), BP every 15–30 min × 2 h [1,2]
4	Administer midday dose	40 mg IV furosemide at ~6 hours after first dose [1]
5	Assess 24-hour response	Daily weight (target 0.5–1.0 kg loss), electrolytes, renal function [1,2]
6	Escalate if inadequate	Double dose (max 160–200 mg/bolus) or add second diuretic class [1,2]
7	Stop if contraindications develop	SBP <90 mmHg, Na <120–125 mmol/L, K <3 mmol/L, anuria [1,2]